Replies to post #336768 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

For example, they could nod to the holders to continue to use the warrants as insurance.

[exwannabe]

It completely depends on what they told the warrants holders.
What inside information could warrant holders gain from the offer to extend the warrants other than when they offered to extend beginning Nov?

If they do not tell them anything, then they are selling a deal while withholding material information.

[FeMike]

The assertion that they could not extend warrants while being unblinded is beyond me. I dont know if they are or are not unblinded, it would also blow my mind if they are not, but the notion that they must be blinded otherwise they can not move the warrants does not stick

If they are unblinded they simply cannot have a negotiation with warrant holders. There is too much risk involved there.

If they are in possession of material information while negotiating one side of a contract and not disclosing that information you're asking for problems.

[flipper44]

I don’t think they’d tell them anything. So to me the question is whether or not there are any sweeteners apart from simply exchanging extension in consideration for suspension. If there are sweetners, I’d say management was not unblinded at the time. If no sweeteners, then I’d say they were blinded and counter intuitively, this should increase pps once terms are clear.

[sentiment_stocks]

It completely depends on what they told the warrants holders.
What inside information could warrant holders gain from the offer to extend the warrants other than when they offered to extend beginning Nov?

From what I have heard from others, no details regarding the trial were shared with the warrant holders, and that only the offer itself was discussed.